ClearOne is trading 6.1% down in pre-market at $9.55 after investors reassessed dilution risks surrounding the Cortigent merger and renewed investor-rights scrutiny.
- The transaction would issue 12.5 million shares to Vivani Medical, leaving existing shareholders with approximately 12.7%–14.4% of the combined company.
- Shares closed at $9.80 on August 6 after rising 166.30%, then closed at $10.17 on August 7.